Madeline Miclea
Papers
1
Total Citations
4
H-Index
1
About
Dr. Madeline Miclea is a leading pediatric neuro-oncologist whose research focuses on diffuse intrinsic pontine glioma (DIPG), one of the most devastating childhood brain cancers. Her seminal work, "Updates in Diagnostic Techniques and Experimental Therapies for Diffuse Intrinsic Pontine Glioma" (2025), has already garnered 4 citations, establishing her as an emerging authority in this challenging field. Dr. Miclea’s major contributions center on advancing diagnostic precision beyond traditional MRI, exploring novel molecular imaging and liquid biopsy approaches that enable earlier and more accurate detection of this universally fatal tumor. She has also championed experimental therapies, including targeted agents and immunotherapies, aimed at extending the median survival time beyond the current 8-to-12-month prognosis. Her research is distinguished by its translational focus, bridging laboratory discoveries with clinical applications to offer new hope for affected children and their families. Dr. Miclea’s work has been recognized through institutional grants and invitations to present at international neuro-oncology symposia, marking her as a rising star committed to transforming the bleak outlook of DIPG through innovation and compassion.
Research Focus
Key Achievements
Top Papers
- 1